Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global In-Silico Drug Discovery Market by Workflow (Discovery (Target Identification, Target Validation and Lead Discovery), Pre-Clinical Tests and Clinical Trials), By Product (Software, and Service),By Software Type(Molecular Modeling and de Novo Drug Design Software and Pharmacophore Modeling Software), By End-User(Contract Research Organizations, Pharmaceutical Industry, Academic and Research Institutes and Other (Hospitals and Other Care Facilities)) and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Global In-Silico Drug Discovery market anticipated propelling as it helps in making more efficient drug discovery and development process with low cost
Global in-silico drug discovery market projected to grow with a remarkable rate during the forecast period, 2020-2027. It is attributable to the rise in demand for in-silico drug discovery to use computational approaches to discover, develop, and analyze drugs in less time. Additionally, the growing adoption of in-silico drug discovery for improvement in drug attrition rates and increased rate of target identification will propel the robust growth of global in-silico drug discovery market size in the next few years. Moreover, in-silico drug discovery techniques assist in delivering new drug candidates more quickly and at a lower cost and increase the chance of success in many stages of the discovery process, which would trigger the global in-silico drug discovery industry in the future time. In-Silico Drug Discovery techniques facilitate accessing a huge amount of data generated and transform the massive complex biological data into workable knowledge.
In-silico techniques help in identifying drug targets via computational tools such as used to analyze the target structures for possible binding active sites and generate candidate molecules. After that, it checks for drug-likeness, and after that docks, these molecules with the target rank them according to their binding affinities and later optimize the molecules to improve binding characteristics. Furthermore, the growing demand for in-silico product which helps in vendors and pharmaceutical companies can develop global off‐the‐shelf products and locally customized products.
Workflow Overview in the Global In-Silico Drug Discovery Market
Based on workflow, the global in-silico drug discovery market classified Discovery (Target Identification, Target Validation, and Lead Discovery), Pre-Clinical Tests, and Clinical Trials. The Discovery segment likely to lead them in-silico drug discovery markets by 2027. It is owing to in-silico methods assist in pharmacokinetic properties for the chemical compounds before the screening for enabling the early detection of the compounds which are more likely to fail in clinical stages. After that, it enhances the detection of promising entities. In-silico techniques evolve three stages, such as target identification, target validation, and lead discovery.
Product Overview in the Global In-Silico Drug Discovery market
Based on the product, the global in-silico drug discovery market bifurcated into software, and Service. The Software segment projected to dominate the in-silico drug discovery market by 2027. It is owing to software-based in-silico drug discovery help in investigation of pharmacokinetic and pharmacodynamic properties of the drug, and structural activity relationship between ligand and its target.
Services segment will trigger in the forecast period on account of companies provides comprehensive in-silico drug techniques services and supports the integration of new drug discovery projects.
Software Type Overview in the Global In-Silico Drug Discovery Market
Based on the software Type, the global In-Silico Drug Discovery market segregated into Molecular Modeling Drug Design Software and Pharmacophore Modeling Software. The Molecular Modeling Drug Design Software segment witnessed a significant market share in the forecast period and will generate maximum revenue by 2027. It is attributable to molecular modeling to assist in generating ideas on compounds or macromolecules 3D conformation and to make predictions on biological activities.
End-User Overview in the Global In-Silico Drug Discovery Market
Based on end-user, the global in-silico drug discovery market categorized into Contract Research Organizations, Pharmaceutical Industry, Academic and Research Institutes, and Other (Hospitals and Other Care Facilities. Pharmaceutical Industry segments estimated to dominate the market by 2027 due to in-silico drug discovery provide an edge to the pharmaceutical industry in drug discovery and drug development with the computational techniques in lesser time.
Regional Overview in the Global In-Silico Drug Discovery Market
By geography, the global in-silico drug discovery market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America anticipated gaining maximum share by 2027 in the in-silico drug discovery market. It is owing to the surge in R&D spending by pharmaceutical and biopharmaceutical companies, coupled with the presence of major players of pharmaceutical companies in these regions.
Global In-Silico Drug Discovery Market: Competitive Landscape
Companies such as Albany Molecular Research Inc., Certara USA, Inc., Charles River, Chemical Computing Group, Collaborative Drug Discovery Inc., Dassault System (Biovia), Evotec A.G., GVK Biosciences Private Limited, ICAGEN, INC. , Novo Informatics Pvt. Ltd., Numerate Inc., PerkinElmer Inc, Schrödinger, LLC, Selvita, Simulation Plus, and WuXi AppTec are the key players in the Global In-Silico Drug Discovery Market. 

Global In-Silico Drug Discovery Market
Report Content
1.	Research Strategic Development
1.1.	Market Modelling
1.2.	Product Analysis
1.3.	Market Trend and Economic Factors Analysis
1.4.	Market Segmental Analysis
1.5.	Geographical Mapping
1.6.	Country Wise Segregation
2.	Research Methodology
2.1.	Identification of Target Market
2.2.	Data Acquisition 
2.3.	Refining of Data/ Data Transformations
2.4.	Data Validation through Primary Techniques
2.5.	Exploratory Data Analysis
2.6.	Graphical Techniques/Analysis
2.7.	Quantitative Techniques/Analysis
2.8.	Visual Result/Presentation 
3.	Executive Summary
4.	Market Insights
4.1.	Economic Factor Analysis 
4.1.1.	Drivers
4.1.2.	Trends
4.1.3.	Opportunities
4.1.4.	Challenges
4.2.	Technological Landscape
4.3.	Competitors & Product Analysis
4.4.	Regulatory Framework
4.5.	Company market share analysis, 2019
4.6.	Porter's Five forces analysis
4.7.	New Investment Analysis
4.8.	PESTEL Analysis
5.	Global In-Silico Drug Discovery Market Overview
5.1.	Market Size & Forecast, 2016-2027
5.1.1.	Demand
5.1.1.1.	By Value (USD Million)
5.2.	Market Share & Forecast, 2016-2027
5.2.1.	By Workflow
5.2.1.1.	Discovery 
5.2.1.1.1.	Target Identification
5.2.1.1.2.	Target Validation
5.2.1.1.3.	 Lead Discovery
5.2.1.2.	Pre-Clinical Tests
5.2.1.3.	Clinical Trials
5.2.2.	By Product
5.2.2.1.	Software
5.2.2.2.	Services
5.2.3.	By Software Type
5.2.3.1.	Molecular Modeling Drug Design Software
5.2.3.2.	Pharmacophore Modeling Software
5.2.4.	By End-User
5.2.4.1.	Contract Research Organizations
5.2.4.2.	Pharmaceutical Industry
5.2.4.3.	Academic and Research Institutes
5.2.4.4.	Other (Hospitals and Other Care Facilities)
5.2.5.	By Region
5.2.5.1.	North America
5.2.5.2.	Europe
5.2.5.3.	Asia Pacific
5.2.5.4.	South America 
5.2.5.5.	Middle East & Africa 
6.	North America In-Silico Drug Discovery Market Overview
6.1.	North America In-Silico Drug Discovery Market Size & Forecast, 2016-2027
6.1.1.	Demand
6.1.1.1.	By Value (USD Million)
6.2.	North America In-Silico Drug Discovery Market Share & Forecast, 2016-2027
6.2.1.	By Workflow
6.2.1.1.	Discovery 
6.2.1.1.1.	Target Identification
6.2.1.1.2.	Target Validation
6.2.1.1.3.	 Lead Discovery
6.2.1.2.	Pre-Clinical Tests
6.2.1.3.	Clinical Trials
6.2.2.	By Product
6.2.2.1.	Software
6.2.2.2.	Services
6.2.3.	By Software Type
6.2.3.1.	Molecular Modeling Drug Design Software
6.2.3.2.	Pharmacophore Modeling Software
6.2.4.	By End-User
6.2.4.1.	Contract Research Organizations
6.2.4.2.	Pharmaceutical Industry
6.2.4.3.	Academic and Research Institutes
6.2.4.4.	Others (Hospitals and Other Care Facilities)
6.2.5.	By Country
6.2.5.1.	US
6.2.5.2.	Canada
6.2.5.3.	Mexico
6.2.6.	Manufacturer & Distributor List (Top 5)
6.2.7.	Company Market Share (Top 3-5)
6.2.8.	Economic Impact Study on North America In-Silico Drug Discovery Market 
7.	Europe In-Silico Drug Discovery Market Overview
7.1.	Europe In-Silico Drug Discovery Market Size & Forecast, 2016-2027
7.1.1.	Demand
7.1.1.1.	By Value (USD Million)
7.2.	Europe In-Silico Drug Discovery Market Share & Forecast, 2016-2027
7.2.1.	By Workflow
7.2.1.1.	Discovery 
7.2.1.1.1.	Target Identification
7.2.1.1.2.	Target Validation
7.2.1.1.3.	 Lead Discovery
7.2.1.2.	Pre-Clinical Tests
7.2.1.3.	Clinical Trials
7.2.2.	By Product
7.2.2.1.	Software
7.2.2.2.	Services
7.2.3.	By Software Type
7.2.3.1.	Molecular Modeling Drug Design Software
7.2.3.2.	Pharmacophore Modeling Software
7.2.4.	By End-User
7.2.4.1.	Contract Research Organizations
7.2.4.2.	Pharmaceutical Industry
7.2.4.3.	Academic and Research Institutes
7.2.4.4.	Others (Hospitals and Other Care Facilities)
7.2.5.	By Country
7.2.5.1.	Germany
7.2.5.2.	UK
7.2.5.3.	France
7.2.5.4.	Italy
7.2.5.5.	Rest of Europe
7.2.6.	Manufacturer & Distributor List (Top 5)
7.2.7.	Company Market Share (Top 3-5)
7.2.8.	Economic Impact Study on Europe In-Silico Drug Discovery Market 
8.	Asia Pacific In-Silico Drug Discovery Market Overview
8.1.	Asia Pacific In-Silico Drug Discovery Market Size & Forecast, 2016-2027
8.1.1.	Demand
8.1.1.1.	By Value (USD Million)
8.2.	Asia Pacific In-Silico Drug Discovery Market Share & Forecast, 2016-2027
8.2.1.	By Workflow
8.2.1.1.	Discovery 
8.2.1.1.1.	Target Identification
8.2.1.1.2.	Target Validation
8.2.1.1.3.	 Lead Discovery
8.2.1.2.	Pre-Clinical Tests
8.2.1.3.	Clinical Trials
8.2.2.	By Product
8.2.2.1.	Software
8.2.2.2.	Services
8.2.3.	By Software Type
8.2.3.1.	Molecular Modeling Drug Design Software
8.2.3.2.	Pharmacophore Modeling Software
8.2.4.	By End-User
8.2.4.1.	Contract Research Organizations
8.2.4.2.	Pharmaceutical Industry
8.2.4.3.	Academic and Research Institutes
8.2.4.4.	Others (Hospitals and Other Care Facilities)
8.2.5.	By Country
8.2.5.1.	China
8.2.5.2.	India
8.2.5.3.	Japan
8.2.5.4.	Australia
8.2.5.5.	Rest of Asia Pacific
8.2.6.	Manufacturer & Distributor List (Top 5)
8.2.7.	Company Market Share (Top 3-5)
8.2.8.	Economic Impact Study on Asia Pacific In-Silico Drug Discovery Market 
9.	South America In-Silico Drug Discovery Market Overview
9.1.	South America In-Silico Drug Discovery Market Size & Forecast, 2016-2027
9.1.1.	Demand
9.1.1.1.	By Value (USD Million)
9.2.	South America In-Silico Drug Discovery Market Share & Forecast, 2016-2027
9.2.1.	By Workflow
9.2.1.1.	Discovery 
9.2.1.1.1.	Target Identification
9.2.1.1.2.	Target Validation
9.2.1.1.3.	 Lead Discovery
9.2.1.2.	Pre-Clinical Tests
9.2.1.3.	Clinical Trials
9.2.2.	By Product
9.2.2.1.	Software
9.2.2.2.	Services
9.2.3.	By Software Type
9.2.3.1.	Molecular Modeling Drug Design Software
9.2.3.2.	Pharmacophore Modeling Software
9.2.4.	By End-User
9.2.4.1.	Contract Research Organizations
9.2.4.2.	Pharmaceutical Industry
9.2.4.3.	Academic and Research Institutes
9.2.4.4.	Others (Hospitals and Other Care Facilities)
9.2.5.	By Country
9.2.5.1.	Brazil
9.2.5.2.	Argentina
9.2.5.3.	Rest of South America
9.2.6.	Manufacturer & Distributor List (Top 5)
9.2.7.	Company Market Share (Top 3-5)
9.2.8.	Economic Impact Study on South America In-Silico Drug Discovery Market
10.	Middle East & Africa In-Silico Drug Discovery Market Overview
10.1.	Middle East & Africa In-Silico Drug Discovery Market Size & Forecast, 2016-2027
10.1.1.	Demand
10.1.1.1.	By Value (USD Million)
10.2.	Middle East & Africa In-Silico Drug Discovery Market Share & Forecast, 2016-2027
10.2.1.	By Workflow
10.2.1.1.	Discovery 
10.2.1.1.1.	Target Identification
10.2.1.1.2.	Target Validation
10.2.1.1.3.	 Lead Discovery
10.2.1.2.	Pre-Clinical Tests
10.2.1.3.	Clinical Trials
10.2.2.	By Product
10.2.2.1.	Software
10.2.2.2.	Services
10.2.3.	By Software Type
10.2.3.1.	Molecular Modeling Drug Design Software
10.2.3.2.	Pharmacophore Modeling Software
10.2.4.	By End-User
10.2.4.1.	Contract Research Organizations
10.2.4.2.	Pharmaceutical Industry
10.2.4.3.	Academic and Research Institutes
10.2.4.4.	Others (Hospitals and Other Care Facilities)
10.2.5.	By Country
10.2.5.1.	Saudi Arabia
10.2.5.2.	UAE
10.2.5.3.	South Africa
10.2.5.4.	Rest of Middle East & Africa
10.2.6.	Manufacturer & Distributor List (Top 5)
10.2.7.	Company Market Share (Top 3-5)
10.2.8.	Economic Impact Study on Middle East & Africa In-Silico Drug Discovery Market
11.	Competitor Analysis
11.1.	Company Description
11.2.	Financial Analysis
11.3.	Key Products
11.4.	Key Management Personnel 
11.5.	Contact Address
11.6.	SWOT Analysis
11.7.	Company Profile
11.7.1.	Albany Molecular Research Inc.
11.7.2.	Certara USA, Inc.
11.7.3.	Charles River
11.7.4.	Chemical Computing Group
11.7.5.	 Collaborative Drug Discovery Inc.
11.7.6.	 Dassault System
11.7.7.	 Evotec A.G.
11.7.8.	 GVK Biosciences Private Limited
11.7.9.	ICAGEN, INC.
11.7.10.	 Novo Informatics Pvt. Ltd.
11.7.11.	Numerate Inc. 
11.7.12.	PerkinElmer Inc
11.7.13.	Schrödinger, LLC
11.7.14.	Selvita
11.7.15.	Simulation Plus
11.7.16.	WuXi AppTec
11.7.17.	  Other Prominent Players

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

Small Molecule Drug Design Software Market Size And Share Analysis - Growth Trends And Foreca...
View More
Protein Drug Screening Validation Database Market Size And Share Analysis - Growth Trends And...
View More
Cloud Based Drug Discovery Platform Market Size And Share Analysis - Growth Trends And Foreca...
View More
Chemical Drug CXO Services Market Size And Share Analysis - Growth Trends And Forecasts (2024...
View More
Drug Management System Market Size And Share Analysis - Growth Trends And Forecasts (2024-203...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved